Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05570630 · ClinicalTrials.gov registry record · NA
VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 6,911
- Enrollment target
NCT05570630 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 6,911 participants.
The verdict
NCT05570630, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,911 participants
- Enrollment target
Study Summary
COVID-19 infection during pregnancy is associated with increased risk of pre-eclampsia, preterm birth and stillbirth. Pregnant people with COVID-19 have a higher rate of ICU admission and intubation than those who are not pregnant. COVID-19 vaccine is recommended before pregnancy and during pregnancy to decrease these risks. Despite the benefits of COVID-19 vaccination, only 71% of pregnant women were vaccinated for COVID-19 as of June 2022 (most prior to pregnancy), with a much lower rate of 58% among non-Hispanic Black women. An effective intervention is needed to improve COVID vaccination rates for pregnant people overall. In this study, the investigators will perform a randomized controlled trial aimed at practice change in obstetricians' offices, with an overall goal of increasing maternal COVID-19 vaccination rates.
Interventions
- OTHER Standard of Care
- BEHAVIORAL VAX-MOM COVID-19 Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,911 participants |
| Start Date | 2022-10-21 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05570630
The ClinicalTrials.gov registry entry for NCT05570630 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6,911 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05570630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05570630 about?
NCT05570630 is a clinical study titled "VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination". COVID-19 infection during pregnancy is associated with increased risk of pre-eclampsia, preterm birth and stillbirth. Pregnant people with COVID-19 have a higher rate of ICU admission and intubation than those who are not pregnant. COVID-19 vaccine is recommended before pregnancy and during pregnanc...
What is the current status of trial NCT05570630?
This trial is currently completed. It is a NA study. The enrollment target is 6,911 participants. The study started on 2022-10-21. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT05570630?
The interventions under investigation include: Standard of Care (OTHER), VAX-MOM COVID-19 Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05570630?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.